Skip to main content

Day: August 20, 2024

Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak

Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) testing Roche confirms that its cobas MPXV test, as well as the LightMix® research use only kits, detect the latest mpox virus variants It is actively working to enhance laboratory testing capacity for mpox worldwideBasel, 20 August 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for mpox, formerly known as monkeypox. Mpox, a viral disease that can spread easily between people and from infected animals, was declared a Public Health Emergency of International Concern by the World Health Organization (WHO) (14 August 2024). Globally, Roche is partnering...

Continue reading

KULR Partners with Amprius Technologies to Develop Reference Design to Enhance Battery Safety and Performance in Advanced Air Mobility

SAN DIEGO, Aug. 20, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a global leader in safe and high-performance energy storage solutions, today announced it has been selected for a pivotal battery pack reference design project by Amprius Technologies (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform. The final reference design will provide Amprius’ customers with a solution to address thermal runaway at the battery pack level that leverages KULR’s advanced energy management platform, KULR ONE Design Solutions, with Amprius’ high-energy Silicon Anode pouch cells to meet the rigorous thermal qualification standards set by the Federal Aviation Administration (FAA) and European Union Aviation Safety Agency (EASA),...

Continue reading

Richtech Robotics Announces ADAM Installation at One Kitchen in Rockford, IL Walmart, Marking First Humanoid Drink Robot in the State

Figure: 1Richtech Robotics Announces ADAM Installation at One Kitchen in Rockford, IL Walmart, Marking First Humanoid Drink Robot in the StateLatest installation furthers a 240-location rollout at One Kitchens across the U.S. and integrates the Company’s new commercial management venture, AlphaMax Management, formed to optimize the integration of the robots into clients’ businesses LAS VEGAS, Aug. 20, 2024 (GLOBE NEWSWIRE) — Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics”), a Nevada-based provider of AI-driven service robots, announces the installation of its advanced robotic beverage system, ADAM, at a One Kitchen in a Rockford, IL Walmart. This milestone marks the second installation as part of a planned rollout across 240 One Kitchen locations in the U.S. One Kitchen restaurants feature multiple national and...

Continue reading

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, announces FDA 510(k) clearance of the iFuse TORQ TNT™ Implant System (TNT). The TNT implant system is designed to meet the specific anatomical and bone mineral density needs of the sacrum and ilium and will serve as the next generation technology for pelvic fragility fracture fixation and sacroiliac joint fusion. TNT includes a porous threaded implant with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and into the contralateral ilium (through and through, “TNT”). TNT was awarded Breakthrough Device Designation (BDD) by the FDA. In designating TNT as a Breakthrough Device, the...

Continue reading

DigiAsia Corp. Appoints Andreas Gregori to its AI Strategic Advisory Board

~ The Addition Strengthens the Delivery of Meaningful AI Fintech Solutions for its Enterprise Clients ~ NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) — DigiAsia Corp. (NASDAQ: FAAS) (“DigiAsia” or the “Company”), a leading Fintech as a Service (“FaaS”) ecosystem provider, today announced that Andreas Gregori, a current member of DigiAsia’s board of directors and highly experienced business executive and entrepreneur, has been appointed as an advisor to its recently established AI strategic advisory board. Mr. Gregori is a seasoned commercial leader with a digital and customer-first mindset. His deep knowledge of leveraging technology and AI in meaningful ways will propel the Company as it rapidly integrates AI solutions to enhance its Fintech offerings for enterprise clients and partners in Indonesia and beyond. Mr. Gregori has over...

Continue reading

AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential of Ampligen and two other drugs OCALA, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced the official print publication of the data analysis from a long-term Early Access Program (“EAP”) studying the company’s drug Ampligen® (rintatolimod) for the treatment of advanced pancreatic ductal adenocarcinoma (“PDAC”). The manuscript titled “Rintatolimod in Advanced Pancreatic Cancer enhances Anti-Tumor Immunity through Dendritic Cell-Mediated T Cell Responses,” appears in the journal Clinical Cancer Research, one of oncology’s most prestigious journals. Ampligen is a dsRNA product candidate that acts via the...

Continue reading

American Rebel Reports Financial Results for the Second Quarter and First Half Ended June 30, 2024

Nashville, TN, Aug. 20, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (americanrebelbeer.com), announced its financial results for the quarter (“Q2 2024”) and first half ended June 30, 2024. Investors are encouraged to read the Company’s quarterly report on Form 10-Q, which was filed with the Securities and Exchange Commissions (the “SEC”) and contains additional information and is posted at https://americanrebel.com/investor-relations. First Half 2024 Financial Summary:Revenue   $ 7.3 Million  Gross Profit   $ 0.87 Million  EBITDA (GAAP)   $ (6.4) Million  Adjusted EBITDA (Non-GAAP)1   $ (3.7) Million  Second...

Continue reading

NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University

Celebrating milestones in patient care and practice enhancement through NeuroStar’s innovative training facility MALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, proudly announces the two-year anniversary of NeuroStar University (NSU). This milestone will be celebrated with a special event held at the NSU training center in Charlotte, North Carolina, showcasing the profound impact of NSU’s pioneering training programs on pioneering new standards in patient care and responsiveness. “NeuroStar University is a key part of our ongoing commitment to supporting our healthcare providers. The skills they gain through this training...

Continue reading

IREN to Release FY24 Results on August 28, 2024

SYDNEY, Australia, Aug. 20, 2024 (GLOBE NEWSWIRE) — IREN (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today announced that it will release its financial results for the full year ended June 30, 2024, on Wednesday, August 28, 2024 and host a conference call beginning at 5:00 p.m. New York time. The webcast will be recorded, and the replay will be accessible shortly after the event at https://iren.com/investor/events-and-presentationsWebcast and Conference Call DetailsTime & Date: 5:00 p.m. New York time, Wednesday, August 28, 2024  7:00 a.m. Sydney time, Thursday, August 29, 2024  Participant Registration Link  Live Webcast Use this link  Phone Dial-In with Live Q&A Use...

Continue reading

Blue Star Foods Strengthens Balance Sheet by Paying Off $645,668 of Debts

Miami, FL, Aug. 20, 2024 (GLOBE NEWSWIRE) — Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (ESG) sustainable seafood company with a focus on Recirculatory Aquaculture Systems (RAS), has taken a significant step towards enhancing its financial position by reducing $645,668 in liabilities after its recently August 14th filling of its 10-Q from the quarter ended June 30, 2024. This move is part of Blue Star’s comprehensive strategy to improve its financial health, which is focused on reducing debt and increasing its shareholder equity.John Keeler, Chairman and CEO of Blue Star Foods, commented, “Our reduction in liabilities by $645,668, management has demonstrated our commitment to fortifying Blue Star’s balance sheet and strengthening...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.